The hottest FDA Regulation Substack posts right now

And their main takeaways
Category
Top Health & Wellness Topics
The DisInformation Chronicle β€’ 2005 implied HN points β€’ 09 Jan 24
  1. FDA Commissioner is promoting products off-label, which is illegal marketing scheme criticized by Democrats
  2. There are concerns about conflicts of interest in reporting on COVID vaccine efficacy
  3. Clinicians may not always see conflicts of interest when receiving payments from pharmaceutical companies
In My Tribe β€’ 789 implied HN points β€’ 11 Jul 23
  1. Marijuana legalization has not significantly reduced excessive incarceration and has increased the use of the drug.
  2. Observational studies suggest a link between chronic cannabis use and mental illnesses like schizophrenia, depression, and bipolar disorder.
  3. There should be strict regulations on marijuana use, with rigorous testing of its medicinal claims and penalties for public use and driving under the influence.
More is Different β€’ 8 implied HN points β€’ 17 Nov 24
  1. Dr. Joseph Gulfo believes the FDA should focus on fast-tracking safe and effective treatments instead of just protecting public health. He says this can help bring more innovative drugs to patients who need them.
  2. Balaji Srinivasan thinks the FDA's rules need to change so it can evaluate drugs and treatments better. He suggests creating new centers at universities to find smarter ways to approve medical products.
  3. Jim O'Neill has some government experience but may not be as strong as the other candidates. People are unsure about his past and whether he can lead the FDA effectively.
Steve Kirsch's newsletter β€’ 13 implied HN points β€’ 18 Dec 24
  1. Pfizer's study suggests that their COVID vaccines may actually raise the risk of serious health issues by up to 71%. This information is concerning and not widely reported.
  2. The research compared vaccinated individuals with unvaccinated ones, and found notable health risks for vaccinated people, such as increased chances of heart problems and other serious conditions.
  3. Despite the alarming findings, there seems to be a lack of transparency from Pfizer and health authorities, leading some to feel that important safety information is being kept under wraps.
philsiarri β€’ 0 implied HN points β€’ 06 Mar 24
  1. FDA authorized the first over-the-counter continuous glucose monitor (CGM), Dexcom Stelo Glucose Biosensor System, for individuals 18 and older not using insulin.
  2. The CGM system aims to help users understand the effects of diet and exercise on blood sugar levels, providing glucose readings every 15 minutes with sensors lasting up to 15 days.
  3. The FDA clearance for this device emphasizes increased health equity by making health monitoring more accessible, although some side effects like skin irritation and pain have been reported.
Get a weekly roundup of the best Substack posts, by hacker news affinity: